Accelerating world class science to deliver transformative regenerative medicine treatments in an equitable manner to a diverse California and world. We are a patient centered funding agency.

Dr. Lila Collins
Associate Director, Therapeutics Development
415-740-8505
This email address is being protected from spambots. You need JavaScript enabled to view it.

eGenesis is committed to revolutionizing organ transplantation with a renewable supply of organs that offers patients durable survival. Learn how we are tackling the critical challenges associated with xenotransplantation to make human compatible organs for transplant a clinical reality.

We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible.

Ms. Veronica Martinez
Brand Lead, Solid Organ Transplant
310-490-8036
This email address is being protected from spambots. You need JavaScript enabled to view it.

Revivicor's vision is to provide organs from gene-edited pigs to overcome the critical shortage of human organs for transplant.

Dr. David Ayares
President and CSO
540-961-5559
This email address is being protected from spambots. You need JavaScript enabled to view it.

Vertex creates new possibilities in medicine so people with serious diseases can live better lives. Our teams at Vertex Cell and Genetic Therapies (VCGT) are experts in cell and gene therapy sciences, leveraging the best technologies, manufacturing capabilities and expertise, with a patients-first philosophy.

Mr. Ean Burgess
Sr. Manager, Medical Operations
857-500-2901
This email address is being protected from spambots. You need JavaScript enabled to view it.

Optipharm have researched xenotransplantation since 2012. Optipharm is the only company which can supply transgenic miniature pig for xenotransplantation in South Korea, besides, Optipharm has the quadruple knock out transgenic miniature pig for xenotransplantation.

Dr. Jayson Ahn
Team Head of Business Development Team
+82 1032392300
This email address is being protected from spambots. You need JavaScript enabled to view it.

Biorep is committed to defeating diabetes by designing, developing, and manufacturing biomedical instruments to support medical researchers in their quest to find the biological cure for Type I diabetes.

Mr. Felipe Echeverri
CEO
305-330-4449
This email address is being protected from spambots. You need JavaScript enabled to view it.

CareDx is committed to improving transplant patient outcomes by providing innovative and intelligent solutions throughout the entire patient journey. With two decades of commitment to transplant patients and care teams, we have developed close partnerships across the transplant ecosystem that grow stronger every day.

Dr. Nishant Dwivedi
Associate Medical Director
508-981-6087
This email address is being protected from spambots. You need JavaScript enabled to view it.

Transplant Genomics aims to improve transplant outcomes through molecular diagnostic tests that detect early signs of graft injury, differentiate among actionable causes, and enable optimization of therapy.

Ms. Rebecca Day
Transplant Manager
510-299-2795
This email address is being protected from spambots. You need JavaScript enabled to view it.

Nordmark Biochemicals offers Collagenase NB tissue dissociation products suitable for isolation of various cell types for research and clinical applications. Pharmaceutical manufacturing standards guarantee stringent quality control and reliable lot-to-lot consistency. Our portfolio includes the world’s first animal-free GMP grade collagenase, Collagenase AF-1 GMP Grade and Neutral Protease AF GMP Grade.

Dr. Katharina Kempkens
Product Manager
+49 151 55827293
This email address is being protected from spambots. You need JavaScript enabled to view it.

Hunan Xeno Life Science is a Chinese Biotech company focused on porcine xenotransplantation. We are working to advance commercialization of porcine islet cell transplantation to treat type 1 diabetes and islet cell transplant with prior or simultaneous kidney transplantation to treat renal failure caused by diabetic nephropathy.

The Otsuka group of companies is a total-healthcare enterprise that aims to contribute to the health of people around the world under the corporate philosophy, “Otsuka-people creating new products for better health worldwide”.

The Scripps Health/Scripps Clinic Biorepository and Bioinformatics Core has continuously evolved and expanded its services to the greater San Diego medical research community, and other scientists around the globe, by providing centralized high-quality bio-specimen and clinical data collection, processing, accessibility, management, distribution, and specialized analytics of bio-specimens — which are the key to development and testing of next-generation diagnostics and treatments.

Dr. Sunil Kurian
Scientific Director
858-554-4371
This email address is being protected from spambots. You need JavaScript enabled to view it.

ScubaTx is a breakthrough organ transplant preservation company established to solve the global unmet need for longer-duration organ preservation technology. ScubaTx has developed a simple, small and affordable device which uses Persufflation to extend the preservation of organs. The device is based on an entirely new system architecture, coupled with state-of-the-art software systems, that oxygenates organs and delivers major advantages over existing systems.

Dr. David Campbell
CEO
+44 7717 275 046
This email address is being protected from spambots. You need JavaScript enabled to view it.

Veloxis Pharmaceuticals, Inc, an Asahi Kasei company, is a fully integrated specialty pharmaceutical company committed to improving the lives of transplant patients. Headquartered in Cary, North Carolina, USA, Veloxis is focused on the global development and commercialization of medications utilized by transplant patients and by patients with serious related diseases. For further information, please visit Veloxis.com.

Ingrid Boswell
Marketing Coordinator
Direct: +1 984 309 4056
Mobile: +1 984 301 6262
This email address is being protected from spambots. You need JavaScript enabled to view it.

VitaCyte manufactures/supplies GMP-Grade purified-defined collagenase & neutral protease enzymes for cell isolation. The collagenase products are characterized by the applicable US Pharmacopeia collagenase analyses and for collagen degradation activity to ensure minimal lot variability. Purified BP Protease or Thermolysin are also sold for preparing defined collagenase-protease mixtures for cell isolation.

Dr. Robert C. McCarthy
President
317-269-7142
This email address is being protected from spambots. You need JavaScript enabled to view it.